AlphaMadera's AlphaVal page computes Central Garden & Pet Company's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag CENT as undervalued, fairly valued, or overvalued.

What is Central Garden & Pet Company's fair value?

Fair value for CENT is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value CENT?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from CENT's most recent reported fundamentals.

CENT - Central Garden & Pet Company

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $54.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 15.8% below fair value

Current Price $44.50

Bear Case $43.52 2.2% downside ($43.52 - $44.50) / $44.50 = -2.2% $3.09 × 14x P/E

Fair Value $52.84 18.7% upside ($52.84 - $44.50) / $44.50 = 18.7% $3.09 × 17x P/E

Bull Case $62.16 39.7% upside ($62.16 - $44.50) / $44.50 = 39.7% $3.09 × 20x P/E

Adjust Assumptions

P/E Multiple

17.0x

Adjusted EPS

3.09$

Key Value Driver

Normalized P/E multiple (17x base case)

Implied Market Multiple 14.4x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $54.00 from 10 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $52.84 per share.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples